| Peritoneal dialysis patients (N=53) |
Average values* |
Minimum-maximum |
Reference values |
| Age, years |
52 ± 12 |
19-75 |
- |
| Gender: men/women |
28 (53%)/25 (47%) |
|
- |
| Dialysis treatment duration, months |
24 (15-51) |
4-100 |
- |
| Observation period, months |
60 (9-72) |
1-72 |
- |
| All-cause mortality |
24 (45%) |
- |
- |
| Cardiovascular mortality |
19 (36%) |
- |
- |
| Active smoking |
11 (21%) |
- |
- |
| Diabetes |
12 (23%) |
- |
- |
| Hypertension |
46 (87%) |
- |
- |
| Left ventricular ejection fraction, % |
64 (60-66) |
45-74 |
55-70 |
| Left ventricular mass, g |
244 ± 78 |
102-423 |
F: 67–162
M: 88–224 |
| Left ventricular mass index, g/m2 |
138 ± 43 |
55-246 |
F: maximum to 110
M:maximum to 125 |
| FRS, points |
8 (5-10) |
8-16 |
- |
| FRS, ten-year risk, % |
10 (6-16) |
1-37 |
- |
| BMI, kg/m2 |
25.2 ± 4.2 |
17.2-34.2 |
20-25 |
| Systolic blood pressure, mmHg |
149 ± 18 |
105-180 |
< 130 |
| Diastolic blood pressure, mmHg |
90 ± 12 |
60-115 |
< 80 |
| Mean arterial pressure, mmHg |
110 ± 11 |
87-133 |
75-100 |
| Hemoglobin, g/dL |
11.9 ± 1.7 |
7.7-15.3 |
12-17 |
| Fibrinogen, g/L |
6.0 ± 1.3 |
2.9-8.6 |
1.8-3.5 |
| WBC, x103/µL |
7.56 ± 2.44 |
2.77-12.36 |
4-10 |
| hsCRP, mg/L |
4.18 (1.29-11.40) |
0.16-35.9 |
<3.17 |
| Albumin, g/L |
38 ± 5 |
20-47 |
35-50 |
| Fasting glucose, mmol/L |
4.7 (4.4-5.4) |
3.4-15.4 |
3.3-5.6 |
| Total cholesterol, mmol/L |
5.54 ± 1.15 |
3.35-9.02 |
3.2-5.2 |
| LDL-cholesterol, mmol/L |
3.25 ± 0.93 |
1.45-6.35 |
0.2-3.4 |
| HDL-cholesterol, mmol/L |
1.41 ± 0.33 |
0.84-2.24 |
0.9-3.0 |
| Triglycerides, mmol/L |
1.95 ± 0.81 |
0.59-3.66 |
0.2-2.3 |
| Ca, mmol/L |
2.30 ± 0.22 |
1.59-2.67 |
2.1-2.4 |
| Pi, mmol/L |
1.78 ± 0.48 |
0.79-2.59 |
1.1-1.8 |
| Ca x Pi, mmol2/L2 |
4.11 ± 1.27 |
1.81-5.99 |
< 4.4 |
| iPTH, pg/mL |
437 (198-836) |
3-2474 |
12-72 |
| FGF23, RU/mL |
3013 (854-12015) |
14.9-38798 |
no data |
| OPG, pmol/L |
9.69 (8.44-13.18) |
3.87-27.48 |
2.5-12.8 ** |
| OC, ng/mL |
65.2 (38.9-70.3) |
10.6-72.5 |
F: 3.7-10.0
M: 3.4-9.1** |
| OPN, ng/mL |
1475 (1038-1870) |
559-3092 |
49.2-175.0** |
| CACS, Agatston units |
92 (0-761) |
0-4555 |
0-100 |
| WCrCl, L/week/1.73 m2 |
66.7 (58.8-85.7) |
43.2-213.8 |
> 45.0 |
* Number of patients (percent) is given for categorical variables; mean ± standard
deviation or median (lower-upper quartile) for continuous variables with normal or
non-normal distribution, respectively.
** Reference ranges established by manufacturer. |
